Altimmune (ALT) Interest & Investment Income (2010 - 2026)
Altimmune (ALT) posted quarterly Interest & Investment Income of $2.9 million for Q1 2026, up 87.77% year-over-year from $1.5 million in Q1 2025, and up 18.99% quarter-over-quarter from $2.4 million in Q4 2025.
Altimmune (ALT) Interest & Investment Income (2010 - 2026) Analysis & Trends
Altimmune (ALT) has reported Interest & Investment Income for 15 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 87.77% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $8.9 million (up 23.47% YoY), while the FY2025 annual figure was $7.5 million, down 6.6% from the prior year.
- Interest & Investment Income rose to $2.9 million in Q1 2026 per ALT's latest filing, from $2.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.9 million in Q1 2026 and bottomed at $21000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.7 million across 5 years, with a median of $1.8 million in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 8000.0% in 2022 and fell as far as 50.0% in 2022.
- Altimmune's Interest & Investment Income stood at $1.5 million in 2022, then surged by 33.79% to $2.0 million in 2023, then decreased by 20.11% to $1.6 million in 2024, then jumped by 55.39% to $2.4 million in 2025, then increased by 18.99% to $2.9 million in 2026.
- Business Quant data shows ALT's Interest & Investment Income at $2.9 million in Q1 2026, $2.4 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 328,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 115,000.00 |
| Sep 30, 2021 | 13,000.00 |